RecruitingNCT06278909
Trigeminal nerve stimulation added to medication for treatment-resistant generalized anxiety
About this title
Read the official source — NCT06278909Device studyAges 18–65Canada
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- KingstonSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 18, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 10
- Sponsor
- Dr. Rafael Freire
- Sponsor type
- Individual investigator
- Study type
- Device
- Intervention type
- Device
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06278909
- Official title
Show the full official title
Trigeminal Nerve Stimulation in Treatment-resistant Generalized Anxiety Disorder: a Feasibility Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Kingston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Dr. Rafael Freire.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
